Wenhua Liu - Publications

The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management.

Journal: Frontiers in endocrinology

Published: December 29, 2025

Advancing understanding of racial disparities in hypertension: does Factor IX illuminate or confound?

Journal: Journal of hypertension

Published: November 06, 2025

Re-evaluating the '12-month' interval for self-monitoring blood pressure: a focus on high-risk populations and dynamic treatment phases.

Journal: Journal of hypertension

Published: October 27, 2025

A powerful lens with a potential blind spot: -quantitative CT in non-IPF fibrotic lung disease.

Journal: American journal of respiratory and critical care medicine

Published: October 27, 2025

Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study.

Journal: Diabetologia

Published: September 03, 2025

When age meets genetics: refining heart failure risk prediction in young atrial fibrillation.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: September 01, 2025

From Representation to Relevance: Powering South Asian Evidence in Cardiovascular RCTs.

Journal: JACC. Asia

Published: August 21, 2025

Same drug, same protocol, different results: is geography the hidden variable in ORBIT trials?

Journal: American journal of respiratory and critical care medicine

Published: August 08, 2025

The evolving landscape of restrictive cardiomyopathy treatment: clinical trial trends and future directions.

Journal: Frontiers in cardiovascular medicine

Published: January 16, 2025

Aromadendrin alleviates LPS-induced kidney apoptosis and inflammation by inhibiting phosphorylation of MAPK and NF-κB signaling pathways.

Journal: Histology and histopathology

Published: June 14, 2024